Doctor profile · Federal record
Dr. Kristina Renfrow, FNP
Nurse Practitioner · Lafayette, IN
- NPI 1346765617
- Accepts Medicare
- MIPS 91.8 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
975 Mezzanine Dr Ste C
Lafayette, IN 479058635
(765) 446-5220
fax (765) 446-5221 - Mailing address
-
Po Box 4699
Lafayette, IN 479034699
Credentials & registration
- NPI registered
- August 2017 — 9 yrs on file
- Profile last updated
- September 12, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Indiana #71007347A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346765617. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
646
Distinct HCPCS
2
Medicare allowed
$54,507
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 362 | 268 | $72 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 284 | 182 | $101 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 208. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$1,943
Transactions
90
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 30 | $336.51 | |
| Lundbeck LLC | 12 | $173.37 | |
| PFIZER INC. | 9 | $142.26 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $129.80 | |
| Lilly USA, LLC | 7 | $117.04 | |
| UCB, Inc. | 4 | $73.01 | |
| Celgene Corporation | 3 | $66.54 | |
| CATALYST PHARMACEUTICALS, INC. | 3 | $65.37 | |
| Amgen Inc. | 3 | $64.39 | |
| ARGENX US, INC. | 2 | $47.84 | |
| BANNER LIFE SCIENCES, LLC | 2 | $46.24 | |
| Eisai Inc. | 3 | $45.64 | |
| SCILEX PHARMACEUTICALS INC. | 2 | $44.96 | |
| LivaNova USA, Inc. | 2 | $43.58 | |
| Teva Pharmaceuticals USA, Inc. | 2 | $41.53 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,577
Patients
759
Total drug cost
$624,392
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 453 | 98 | $12,543 |
| Pregabalin | Generic | 389 | 63 | $30,943 |
| Donepezil Hcl | Generic | 362 | 96 | $6,374 |
| Duloxetine Hcl | Generic | 337 | 76 | $13,417 |
| Topiramate | Generic | 293 | 69 | $6,208 |
| Primidone | Generic | 239 | 52 | $8,552 |
| Memantine Hcl | Generic | 213 | 50 | $6,440 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 211 | 49 | $8,824 |
| Aimovig Autoinjector (Erenumab-Aooe) | Brand | 203 | 29 | $193,617 |
| Levetiracetam | Generic | 178 | 33 | $6,987 |
Hospital affiliations
Frequently asked questions
What is Dr. Kristina Renfrow's medical specialty?
Dr. Kristina Renfrow practices Nurse Practitioner in Lafayette, IN.
Where does Dr. Kristina Renfrow practice?
Dr. Kristina Renfrow practices at 975 Mezzanine Dr Ste C, Lafayette, IN 479058635. Office phone: 7654465220.
What is Dr. Kristina Renfrow's NPI?
Dr. Kristina Renfrow's National Provider Identifier (NPI) is 1346765617, issued by NPPES.
Does Dr. Kristina Renfrow accept Medicare assignment?
Yes. Dr. Kristina Renfrow accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kristina Renfrow commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.